Smart knee replacement: data platform aims to cut risks

NCT ID NCT05302934

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will enroll 600 people getting total knee replacements to test a data platform called Pheno4U. Participants will use a sensor and a smartphone app to track their recovery. The goal is to identify unknown risks or side effects and improve personalized care. The study does not test a new drug or implant, but rather a way to collect and analyze patient data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pheno4U data platform (device and app-based monitoring)
What this could lead to
If successful, this could help doctors personalize knee replacement care and reduce complications by spotting risks early.
What could go wrong
This is an early pilot study focused on data collection, not a treatment test. It may not lead to direct patient benefits or change standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INSTABILITY OF KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Nottingham University Hospital NHS Trust

    NOT_YET_RECRUITING

    Nottingham, NG7 2UH, United Kingdom

  • Universitätsklinikum Carl Gustav Carus

    NOT_YET_RECRUITING

    Dresden, Saxony, 01307, Germany

  • Vincentius Krankenhaus

    RECRUITING

    Konstanz, Baden-Wurttemberg, 78464, Germany

  • Waldkliniken Eisenberg

    RECRUITING

    Eisenberg, Thuringia, 07607, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.